Inventor · disambiguated record
Derun Li
Also filed as: LI DERUN
28 granted patents·8 pending applications·20 citations·filing 2008–2025
92Inventor score
Files withMERCK SHARP & DOHME16MERCK SHARP & DOHME LLC9NIMBUS WADJET INC6GIAMBASU GEORGE MADALIN1HARVARD COLLEGE1
Top patents by PatentIndex Score
36 records- 0186US9688644B2Synthesis of Tetracyclines and intermediates theretoHARVARD COLLEGE·Filed 2015·Granted Jun 27, 2017·3 cites·21 claims
- 0285US9073829B2Synthesis of tetracyclines and intermediates theretoMYERS ANDREW G·Filed 2010·Granted Jul 7, 2015·5 cites·20 claims
- 0381US11028092B2Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jun 8, 2021·2 cites·24 claims
- 0481US10995085B2Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2020·Granted May 4, 2021·1 cites·12 claims
- 0579US2025034136A1Wrn inhibitorsNIMBUS WADJET INC·Filed 2024·Application pending·0 cites
- 0678US12030872B2N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 9, 2024·2 cites·15 claims
- 0778US10934294B2Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Mar 2, 2021·2 cites·13 claims
- 0878US9527875B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2013·Granted Dec 27, 2016·4 cites·13 claims
- 0973US10414774B2Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc diseaseMERCK SHARP & DOHME·Filed 2017·Granted Sep 17, 2019·1 cites·18 claims
- 1070US12421233B2WRN inhibitorsNIMBUS WADJET INC·Filed 2025·Granted Sep 23, 2025·0 cites·20 claims
- 1170US12344609B2WRN inhibitorsNIMBUS WADJET INC·Filed 2025·Granted Jul 1, 2025·0 cites·26 claims
- 1263US10647705B2Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted May 12, 2020·0 cites·16 claims
- 1363US2025206738A1Wrn inhibitorsNIMBUS WADJET INC·Filed 2024·Application pending·0 cites
- 1462US2025129069A1Triazolo wrn inhibitorsNIMBUS WADJET INC·Filed 2024·Application pending·0 cites
- 1559US2025171447A1Adenosine receptor antagonists, pharmaceutical compositions and their use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1653US2024246937A1Il4i1 inhibitors and methods of useGIAMBASU GEORGE MADALIN·Filed 2022·Application pending·0 cites
- 1751US12065438B2Substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Aug 20, 2024·0 cites·19 claims
- 1851US2025368646A1Tricyclic fused wrn inhibitorsNIMBUS WADJET INC·Filed 2025·Application pending·0 cites
- 1950US12275729B2Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME LLC·Filed 2018·Granted Apr 15, 2025·0 cites·5 claims
- 2048US12319671B21-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 3, 2025·0 cites·16 claims
- 2148US11111232B2Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Sep 7, 2021·0 cites·20 claims
- 2248US2023140132A1Arginase inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2020·Application pending·0 cites
- 2347US12440496B2Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetesMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 14, 2025·0 cites·15 claims
- 2447US11498904B2Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Nov 15, 2022·0 cites·14 claims
- 2547US11208407B2Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Dec 28, 2021·0 cites·16 claims
- 2647US2022281886A1Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetesMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 2746US11319283B2Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted May 3, 2022·0 cites·7 claims
- 2846US11274111B2Arginase inhibitors and methods of useMERCK SHARP & DOHME·Filed 2019·Granted Mar 15, 2022·0 cites·19 claims
- 2945US12240867B2Arginase inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 4, 2025·0 cites·23 claims
- 3045US12215116B2Arginase inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2019·Granted Feb 4, 2025·0 cites·46 claims
- 3144US11034661B2Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Jun 15, 2021·0 cites·19 claims
- 3244US10927086B2Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Feb 23, 2021·0 cites·20 claims
- 3342US10988487B2Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Apr 27, 2021·0 cites·20 claims
- 3442US8334405B2Chiral thiourea compounds and process for enantioselective reduction of ketonesLI DERUN·Filed 2008·Granted Dec 18, 2012·0 cites·18 claims
- 3540US9695198B2Factor IXa inhibitorsSMITH CAMERON JAMES·Filed 2013·Granted Jul 4, 2017·0 cites·5 claims
- 3638US10414775B2Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic diseaseMERCK SHARP & DOHME·Filed 2017·Granted Sep 17, 2019·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Derun Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →